Pliant Therapeutics Inc (PLRX)

12.27 -0.93  -7.05% NASDAQ Dec 3, 16:00 12.20 -0.07  -0.57% After-Hours: 20:00 USD

Pliant Therapeutics Cash from Operations (TTM):

-72.06M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 2019. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -72.06M
June 30, 2021 -65.34M
March 31, 2021 -38.17M
Dec. 31, 2020 -37.27M
Sept. 30, 2020 15.96M
June 30, 2020 16.87M
March 31, 2020 -4.669M
Dec. 31, 2019 -2.75M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Benchmarks

Atara Biotherapeutics Inc -190.37M
Jaguar Health Inc -30.11M
Progenity Inc -198.12M

Cash from Operations (TTM) Range, Past 5 Years

Minimum -72.06M Sep 2021
Maximum 16.87M Jun 2020
Average -23.43M


Top Premarket Gainers
MT Newswires 09/07 08:09 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.